Market Research Logo

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis 2013-2018 and Forecast 2019-2025

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis 2013-2018 and Forecast 2019-2025

This report studies the Chemotherapy Induced Peripheral Neuropathy Treatment market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Chemotherapy Induced Peripheral Neuropathy Treatment market by product type and applications/end industries.

In the last several years, global market of Chemotherapy Induced Peripheral Neuropathy Treatment developed rapidly, with an average growth rate of 6.78%. In 2017, global revenue of Chemotherapy Induced Peripheral Neuropathy Treatment is nearly 1302 M USD; the actual Sales is about 77876 thousand units.

The major players in global Chemotherapy Induced Peripheral Neuropathy Treatment market include
Aptinyx
Asahi Kasei Pharma
Regenacy Pharmaceuticals
MAKScientific
Metys Pharmaceuticals
Nemus Bioscience
PledPharma
Sova Pharmaceuticals
DermaXon
Immune Pharmaceuticals
Kineta
Krenitsky Pharmaceuticals
PeriphaGen
Apexian Pharma
WinSanTor
Solasia Pharma

Geographically, this report is segmented into several key Regions, with Sales, revenue, Market Share (%) and Growth Rate (%) of Chemotherapy Induced Peripheral Neuropathy Treatment in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Chemotherapy Induced Peripheral Neuropathy Treatment market is primarily split into
Calcium Channel ¦Á2-delta Ligands
Antidepressants
Opioids
Others

On the basis of applications the Chemotherapy Induced Peripheral Neuropathy Treatment market is primarily split into
Platinum Agents
Taxanes
Vinca Alkaloids
Others


1 Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview
1.1 Chemotherapy Induced Peripheral Neuropathy Treatment Product Overview
1.2 Chemotherapy Induced Peripheral Neuropathy Treatment Segment by Types (Product Category)
1.2.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Comparison by Types (2013-2025)
1.2.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Types in 2017
1.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Segment by Applications
1.3.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Comparison by Applications (2013-2025)
1.3.2 Platinum Agents
1.3.3 Taxanes
1.3.4 Vinca Alkaloids
1.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Regions
1.4.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Regions
1.4.2 North America Chemotherapy Induced Peripheral Neuropathy Treatment Status and Prospect (2013-2025)
1.4.3 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Status and Prospect (2013-2025)
1.4.4 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Status and Prospect (2013-2025)
1.4.5 South America Chemotherapy Induced Peripheral Neuropathy Treatment Status and Prospect (2013-2025)
1.4.6 Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Status and Prospect (2013-2025)
1.5 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size
1.5.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Status and Outlook (2013-2025)
1.5.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Status and Outlook (2013-2025)
1.6 Global Chemotherapy Induced Peripheral Neuropathy Treatment Number of Patients by Regions 2017
2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Competition by Manufacturers/Brand
2.1 Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Products and Clinical Stages
2.2 Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Headquarters, Established Date and Product Types
2.3 Major Cancer Analysis
2.3.1 Colorectal Cancer
2.3.2 Lung Cancer
2.3.3 Pancreatic Cancer
2.3.4 Breast Cancer
2.3.5 Prostate Cancer
2.3.6 Other Cancer
3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue by Regions
3.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Market Share by Regions (2013-2018)
3.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue by Regions (2013-2018)
3.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
3.4 North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
3.5 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
3.6 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
3.7 South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
3.8 Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price Trend by Types
4.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Types (2013-2018)
4.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue by Types (2013-2018)
4.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Price by Type (2013-2018)
4.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Growth by Type (2013-2018)
5 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis by Applications
5.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Market Share by Applications (2013-2018)
5.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Growth Rate by Applications (2013-2018)
6 Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment Industry Key Manufacturers
6.1 Aptinyx Inc
6.1.1 Company Profile
6.1.2 Product Information
6.2 Asahi Kasei Pharma Corp
6.2.1 Company Profile
6.2.2 Product Information
6.3 Regenacy Pharmaceuticals
6.3.1 Company Profile
6.3.2 Product Information
6.4 MAKScientific LLC
6.4.1 Company Profile
6.4.2 Product Information
6.5 Metys Pharmaceuticals AG
6.5.1 Company Profile
6.5.2 Product Information
6.6 Nemus Bioscience Inc
6.6.1 Company Profile
6.6.2 Product Information
6.7 PledPharma
6.7.1 Company Profile
6.7.2 Product Information
6.8 Sova Pharmaceuticals Inc
6.8.1 Company Profile
6.8.2 Product Information
6.9 DermaXon LLC
6.9.1 Company Profile
6.9.2 Product Information
6.10 Immune Pharmaceuticals Inc
6.10.1 Company Profile
6.10.2 Product Information
6.11 Kineta Inc
6.11.1 Company Profile
6.11.2 Product Information
6.12 Krenitsky Pharmaceuticals Inc
6.12.1 Company Profile
6.12.2 Product Information
6.13 PeriphaGen
6.13.1 Company Profile
6.13.2 Product Information
6.14 Apexian Pharma
6.14.1 Company Profile
6.14.2 Product Information
6.15 WinSanTor
6.15.1 Company Profile
6.15.2 Product Information
6.16 Solasia Pharma K.K.
6.16.1 Company Profile
6.16.2 Product Information
7 Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturing Cost Analysis
7.1 Chemotherapy Induced Peripheral Neuropathy Treatment Drugs R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast
11.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue Forecast
11.1.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate Forecast (2019-2025)
11.1.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate Forecast (2019-2025)
11.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Revenue Forecast by Regions (2019-2025)
11.2.1 North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Revenue Forecast (2019-2025)
11.2.2 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Revenue Forecast (2019-2025)
11.2.3 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Revenue Forecast (2019-2025)
11.2.4 South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Revenue Forecast (2019-2025)
11.2.5 Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Revenue Forecast (2019-2025)
11.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price Forecast by Type (2019-2025)
11.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) Comparison by Types (2013-2025)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Types in 2017
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) Comparison by Applications (2013-2025)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Applications in 2017
Table Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) Comparison by Regions 2013-2025
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) and Growth Rate (2013-2025)
Figure Europe Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) and Growth Rate (2013-2025)
Figure South America Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) and Growth Rate (2013-2025)
Figure Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) and Growth Rate (2013-2025)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) Status and Outlook (2013-2025)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) Status and Outlook (2013-2025)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Number of Patients by Regions 2017 (Thousand)
Table Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Products and Clinical Stages
Table Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Headquarters and Established Date
Table Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Product Category
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016
Top 20 Countries Highest Incidence of Lung Cancer in 2016
Figure Percent of New Cases by Age Group: Lung Cancer
Figure Percent of Deaths by Age Group: Lung Cancer
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016
Top 20 Countries Highest Incidence of Breast Cancer in 2016
Figure Percent of New Cases by Age Group: Prostate Cancer
Figure Percent of Deaths by Age Group: Prostate Cancer
Figure Estimated Prostate Cancer Incidence Worldwide in 2016
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) by Regions (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Regions (2013-2018)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Regions (2013-2018)
Figure 2017 Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Regions
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) by Regions (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share by Regions (2013-2018)
Figure 2017 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share by Regions
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume (K Unit) by Regions (2013-2018)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales Value (M USD) by Regions (2013-2018)
Table Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) by Types (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Types (2013-2018)
Figure Sales Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Types (2013-2018)
Figure 2017 Sales Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Types
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) by Types (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Share by Types (2013-2018)
Figure Revenue Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Types (2013-2018)
Figure 2017 Revenue Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Types
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Price (USD/Unit) by Types (2013-2018)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Growth by Type (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) by Applications (2013-2018)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Applications (2013-2018)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Applications (2013-2018)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share by Applications in 2017
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Growth Rate by Applications (2013-2018)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Growth Rate by Applications (2013-2018)
Table Aptinyx Inc Company Profile
Table Asahi Kasei Pharma Corp Company Profile
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Product Picture of Asahi Kasei Pharma Corp
Table Regenacy Pharmaceuticals Company Profile
Table MAKScientific LLC Company Profile
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Product Picture of MAKScientific LLC
Table Metys Pharmaceuticals AG Company Profile
Table Nemus Bioscience Inc Company Profile
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Product Picture of Nemus Bioscience Inc
Table PledPharma Company Profile
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Product Picture of PledPharma
Table Sova Pharmaceuticals Inc Company Profile
Table DermaXon LLC Company Profile
Table Immune Pharmaceuticals Inc Company Profile
Table Kineta Inc Company Profile
Table Krenitsky Pharmaceuticals Inc Company Profile
Table PeriphaGen Company Profile
Table Apexian Pharma Company Profile
Table WinSanTor Company Profile
Table Solasia Pharma K.K. Company Profile
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Product Picture of Solasia Pharma K.K.
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Chemotherapy Induced Peripheral Neuropathy Treatment Drugs
Figure Assessment of API Manufacturing Cost By Region
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour)
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost of Employing a Factory Worker
Figure 2015 Estimated Labor Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year)
Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month)
Table 2015 Global Electricity Price of Industry (USD/KWh) by Country
Figure Manufacturing Process Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment Drugs
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Industrial Chain Analysis
Table Major Buyers of Chemotherapy Induced Peripheral Neuropathy Treatment
Figure Setting Pricing Policy
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 annual Average
Figure USA GDP 2008-2016 (Billion USD)
Figure USA GDP Growth Rate Change 2015-2018
Figure EU GDP 2008-2016 (Billion USD)
Figure EU GDP Growth Rate Change 2015-2018
Figure Germany GDP 2008-2016 (Billion USD)
Figure Germany GDP Growth Rate 2015-2018
Figure UK GDP 2008-2016 (Billion USD)
Figure UK GDP Growth Rate 2015-2018
Figure Italy GDP 2008-2016 (Billion USD)
Figure Italy GDP Growth Rate 2015-2018
Figure France GDP 2008-2016 (Billion USD)
Figure France GDP Growth Rate 2015-2018
Figure Japan GDP 2008-2016 (Billion USD)
Figure Japan GDP Growth Rate 2015-2018
Figure China GDP 2008-2016 (Billion USD)
Figure China GDP Growth Rate 2015-2018
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) and Growth Rate Forecast (2019-2025)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (M USD) and Growth Rate Forecast (2019-2025)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) Forecast by Regions (2019-2025)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share Forecast by Regions (2019-2025)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales (K Unit) and Growth Rate Forecast (2019-2025)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report